Tamiflu Developer Calls Hong Kong Tamiflu Restriction ‘Stupid’
This article was originally published in PharmAsia News
Executive Summary
A scientist who helped develop Roche Holding's Tamiflu (oseltamivir phosphate) drug says the effort by Hong Kong authorities to restrict dispensing of the drug during a recent flu outbreak was stupid. Authorities advised physicians to limit the drug to patients suffering complications, fearing overuse could cause resistance. Graeme Laver, a professor who helped develop the drug, said the virus on which Tamiflu is based will not mutate into a resistant variety and urged it be given on a non-prescription basis. (Click here for more
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.